Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cell & Gene Therapy
Pharma
Lack of global regulatory alignment spurs bad actors, FDA says
If a gene therapy is approved in the U.S., patients in Brazil can sue for access. It’s why global regulators need to work together, Peter Marks said.
Annalee Armstrong
May 9, 2024 10:15am
Vertex's Casgevy launch progresses as CF drugs post solid growth
May 7, 2024 11:23am
Gilead writes $2.4B off Trodelvy as CEO underscores focus
Apr 26, 2024 11:21am
Leqembi, Takeda, Fujifilm Diosynth—Fierce Pharma Asia
Apr 19, 2024 9:20am
CDMO Ascend links up with gene therapy firm Beacon Therapeutics
Apr 9, 2024 10:59am
Thermo Fisher to lay off staffers at California plasmids plant
Apr 9, 2024 8:17am
More News
J&J, Legend's Carvykti quickly leaps ahead of BMS' rival CAR-T
Apr 8, 2024 8:30am
BMS' Abecma wins earlier myeloma nod with updated boxed warning
Apr 5, 2024 11:46am
Novo, Novartis, Merck KGaA, Kyowa Kirin—Fierce Pharma Asia
Mar 22, 2024 8:45am
UPDATED: FDA advisers back Carvykti, Abecma in earlier myeloma
Mar 15, 2024 1:58pm
See more stories